Recruiting
Diabetes Registry Graz for Biomarker Research
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
ClinicalTrials.gov IDNCT05324488
PhaseNot Applicable
Enrollment2000
SponsorMedical University of Graz
Age18 Years
SexALL
Conditions studied
Type1diabetes, Type 2 Diabetes, Adiposity
About this study
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
Interventions
- Other: No intervention — In this registry no intervention is carried out
Primary outcomes
- Biomarker identification (Over entire period of registry (20 years))
Eligibility information
Inclusion Criteria:
* 18 - 99 years
* Informed consent has to be given in written form
* At least one of the following diseases:
* Type 1 diabetes
* Type 2 diabetes
* Type 3 diabetes
* Maturity onset diabetes of young (MODY)
* Late onset diabetes of the adult (LADA)
* Adipositas (BMI \> 30kg/m2)
* Lipid metabolism disorder
Exclusion Criteria:
* No written informed consent
* No willingness to participate in this registry
Study locations
- Medical University of Graz, Graz, 8010 Austria
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.